BioMarin Pharmaceutical Price Target Maintained With a $110.00/Share by Cantor Fitzgerald
Biomarin Pharmaceutical Analyst Ratings
BioMarin Pharmaceutical (BMRN) Receives a Buy From Piper Sandler
Biomarin Pharmaceutical Analyst Ratings
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and BioMarin Pharmaceutical (BMRN)
Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104
Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Ionis Pharmaceuticals (IONS)
Biomarin Pharmaceutical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Idexx Laboratories (IDXX) and ImmunityBio (IBRX)
BioMarin Pharmaceutical Hold Rating: Potential for Voxzogo Label Expansion Amidst Early Data and Upcoming Trials
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Conmed (CNMD) and BioMarin Pharmaceutical (BMRN)
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)
Biomarin Pharmaceutical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Earnings and Voxzogo's Growth Potential
Scotiabank Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Universal Health (UHS)
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Evolent Health (EVH) and BioMarin Pharmaceutical (BMRN)
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN)